RxDoctor Payments Data

Anna Ellis, APRN

Family · Reno, NVNPI 1285032482

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.6% of the total across 282 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,314, 6.8 times the $487 reported in 2022. Among family clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,289in general payments, 2019–2025

Across 282 payments — averaging $25.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$985
  • Sanofi$864
  • Johnson & Johnson$640
  • Sun Pharmaceutical Industries Inc.$637
  • LEO Pharma Inc.$464
  • plus $3K from 15 others

What the payments were for

  • Food & beverage$6,82094%
  • Education$4696%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,289 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Medicare billing

Part B allowed, 2024
$119,673
Medicare patients
510
Services billed
2,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab29$112,335
Fluorouracil65$3,765
Betamethasone Dipropionate31$1,405
Clobetasol Propionate28$1,325
Metronidazole19$1,075
Ketoconazole51$1,017
Triamcinolone Acetonide104$965
Clindamycin Phosphate15$550
Doxycycline Hyclate25$444
ValacyclovirValacyclovir Hcl18$377
CiclopiroxCiclopirox Olamine13$294
Mupirocin17$111
Hydrocortisone11$33

Paid to pharmacies, not to this prescriber.

Other family in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →